The Polycystic Kidney Disease Research Resource Consortium (PKD RRC) develops and shares investigative resources, reagents and expertise with the broader research community to accelerate innovation and discovery in the field of polycystic kidney disease. Explore our resources and core services to see how we can help you advance your research goals.
News, Events & Publications
@pkdresearch.bsky.social on Bluesky
Recent Publications
- Beyond Hematuria: An Unexpected Diagnosis of Autosomal Dominant Polycystic Kidney Disease in a Young Adult Without a Family History.
- Case Report: transient migratory pulmonary nodules with bronchial artery malformations in an autosomal dominant polycystic kidney disease patient: a case of recurrent hemoptysis.
- Evaluation of potential relationship between CFTR modulators, CFTR and neuropsychiatric symptoms in CF.
- Mechanisms Underlying Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
- Oligonucleotide correction of a rare CFTR intron 12 splicing variant from a cystic fibrosis patient.
- Short-term effects of an SGLT2 inhibitor on divalent ions in autosomal dominant polycystic kidney disease: a randomized crossover trial.
- Diagnostic disclosure, communication quality, and patient experience in autosomal dominant polycystic kidney disease.
- Role of CFTR gene mutation variants according to the CFTR-France database in idiopathic pancreatitis: does the type matter?
- Cutaneous adverse reactions following initiation of vanzacaftor/tezacaftor/deutivacaftor in CFTR-modulator-naïve subjects: a case series.
- Neutrophil Elastase Regulates CFTR Function in Airway Disease.
- When cystic fibrosis is not the answer: reclassification and follow-up of children with an unresolved diagnosis after extended CFTR gene analysis.
- The Dosage Logic of PKD1: RNA Regulation and Therapeutic Derepression.
- Risk of Venous Thromboembolism in Kidney Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease.
- CFTR Modulation by Plantago asiatica Flavonoids: A Potential Antisecretory Mechanism Against Diarrhoea.
- Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Randomized Controlled Trial.
- Impact of CFTR modulators on caregiver burden in cystic fibrosis: a cross-sectional study in Brazil.
- Impact of female CFTR variant carrier status on reproductive outcomes.
- Nephromegaly-driven malnutrition in autosomal dominant polycystic kidney disease - Authors' reply.
- Nephromegaly-driven malnutrition in autosomal dominant polycystic kidney disease.
- MEDA-PKD: a dynamic, real-time analytics platform for precision care in autosomal dominant polycystic kidney disease.
- Roflumilast mitigates cartilage degeneration in osteoarthritis by activating CFTR-mediated anti-apoptotic signaling.
- Correction to: Ultrasound Localization Microscopy to Assess the Intrarenal Microvasculature in Autosomal Dominant Polycystic Kidney Disease.
- Circadian rhythms and sleep disturbances: a conceptual perspective with implications for autosomal dominant polycystic kidney disease.
- Extensive Parenchymal Brain Calcification in a Patient With Autosomal Dominant Polycystic Kidney Disease and Stage 5 Chronic Kidney Disease.
- CFTR I556V Variant Exacerbates Cigarette Smoke-Induced Airway Inflammation in COPD by Promoting NLRP3 Inflammasome Activation.
- Case Report: Early-onset portal hypertension revealing pediatric ADPKD with a truncating PKD1 variant.
